Significance of anti-Mi2 antibodies in polymyositis (PM) and dermatomyositis (DM).

被引：0
|
作者：
Roux, S
Palazzo, E
Moosbrugger, I
Haim, T
Hayem, G
Renz, M
Hachulla, E
Kahn, MF
Seelig, HP
Meyer, O
机构：
[1] HOP BICHAT,F-75877 PARIS,FRANCE
[2] CLAUDE HURIEZ HOSP,LILLE,FRANCE
[3] INST IMMUNOL & MOL GENET,KARLSRUHE,GERMANY
来源：
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：702 / 702
页数：1
相关论文
共 50 条
  • [1] Fatal haemophagocytic syndrome in the course of dermatomyositis with anti-Mi2 antibodies
    Madaule, S
    Porte, L
    Couret, B
    Arlet-Suau, E
    RHEUMATOLOGY, 2000, 39 (10) : 1157 - 1158
  • [2] Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis
    Roux, S
    Seelig, HP
    Meyer, O
    JOURNAL OF RHEUMATOLOGY, 1998, 25 (02) : 395 - 396
  • [3] Anti-Mi2 Dermatomyositis Revisited: Pure DM Phenotype with Muscle Fiber Necrosis and High Risk of Malignancy
    Landon-Cardinal, Oceane
    Monseau, Gregoire
    Schoindre, Yoland
    Rigolet, Aude
    Champtiaux, Nicolas
    Hervier, Baptiste
    Masseau, Agathe
    Hachulla, Eric
    Papo, Thomas
    Terrier, Benjamin
    Meyer, Alain
    Kahn, Jean-Emmanuel
    Maurier, Francois
    Gaches, Francis
    Salort-Campana, Emmanuelle
    Zenone, Thierry
    Costedoat-Chalumeau, Nathalie
    Perez, Florian
    Samson, Maxime
    Piette, Anne-Marie
    Moulis, Guillaume
    Audia, Sylvain
    Genot, Severine
    Schleinitz, Nicolas
    Lefevre, Guillaume
    Verneuil, Laurence
    Benveniste, Olivier
    Allenbach, Yves
    Bienvenu, Boris
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [4] Anti-Mi2 dermatomyositis revisited: pure DM phenotype with muscle fiber necrosis and high risk of malignancy
    Landon-Cardinal, O.
    Monseau, G.
    Schoindre, Y.
    Rigolet, A.
    Champtiaux, N.
    Hervier, B.
    Masseau, A.
    Hachulla, E.
    Papo, T.
    Terrier, B.
    Meyer, A.
    Maurier, F.
    Gaches, F.
    Salort-Campana, E.
    Audia, S.
    Bouvier, A.
    Stenzel, W.
    Benveniste, .
    Bienvenu, B.
    Allenbach, Y.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S153 - S153
  • [5] PULMONARY MANIFESTATIONS OF POLYMYOSITIS (PM) AND DERMATOMYOSITIS (DM)
    ZAVILLA, N
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1987, 16 (01) : 75 - 75
  • [6] ESOPHAGEAL MANOMETRIC ABNORMALITIES IN POLYMYOSITIS (PM) AND DERMATOMYOSITIS (DM)
    JACOB, H
    BERKOWITZ, D
    MCDONALD, EG
    BERNSTEIN, LH
    BENEVENTANO, T
    GASTROENTEROLOGY, 1982, 82 (05) : 1091 - 1091
  • [7] CARDIAC INVOLVEMENT IN POLYMYOSITIS AND DERMATOMYOSITIS (PM-DM)
    YOSHII, A
    GOTO, T
    KONDO, H
    KASHIWAZAKI, S
    JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE, 1980, 69 (05): : 535 - 540
  • [8] HISTOLOGICAL AND MORPHOMETRIC STUDIES IN POLYMYOSITIS (PM) AND DERMATOMYOSITIS (DM)
    SCHWARZ, HA
    SLAVIN, G
    ANSELL, BM
    ANNALS OF THE RHEUMATIC DISEASES, 1980, 39 (02) : 186 - 186
  • [9] CLINICAL AND HISTOLOGICAL SPECTRUM OF ANTI-MI2 DERMATOMYOSITIS: A MULTICENTRE RETROSPECTIVE COHORT
    Fornaro, M.
    Girolamo, F.
    Cavagna, L.
    Franceschini, F.
    Giannini, M.
    Zanframundo, G.
    Fredi, M.
    Tampoia, M.
    Amati, A.
    Serlenga, L.
    Lia, A.
    Moschetti, L.
    Dabbicco, D.
    Coladonato, L.
    Iannone, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 399 - 399
  • [10] CLINICAL AND LABORATORY FEATURES OF PATIENTS WITH POLYMYOSITIS (PM) AND DERMATOMYOSITIS (DM)
    HOLDEN, DJ
    BROWNELL, AKW
    FRITZLER, MJ
    CLINICAL RESEARCH, 1982, 30 (01): : A53 - A53
12345